AngioDynamics Stock News

New York State Common Retirement Fund lowered its holdings in AngioDynamics, Inc. (NASDAQ:ANGO) by 54.9% during the 4th quarter, according to the company in its most recent disclosure with the Securit

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Th

In 2016 Jim Clemmer was appointed CEO of AngioDynamics, Inc. (NASDAQ:ANGO). This analysis aims first to contrast CEO...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) 89bio Inc (NASDAQ: ETNB ) Arcus Biosciences Inc (N

New York, March 04, 2020 -- Reportlinker.com announces the release of the report "Global Urological Catheters Industry" - https://www.reportlinker.com/p05151475/?utm_source=GNW.

AngioDynamics (NASDAQ:ANGO) was upgraded by ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports. NASDAQ:

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (...

Newark, NJ, Feb. 28, 2020 -- As per the report published by Fior Markets, the global varicose vein treatment market is expected to grow from USD 231.05 Million in 2017 to USD.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular dise